Abrdn Healthcare Investors (HQH)
NYSE: HQH · Real-Time Price · USD
18.38
+0.12 (0.66%)
Oct 11, 2024, 4:00 PM EDT - Market closed

Company Description

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.

It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.

The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio.

The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index.

Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Abrdn Healthcare Investors
Abrdn Healthcare Investors logo
Country United States
Founded 1986
Industry Asset Management
Sector Financials
CEO Ph.D. Dr. Daniel R. Omstead M.S

Contact Details

Address:
1900 Market Street, Suite 200
Philadelphia, Pennsylvania 19103
United States
Phone 215 405 5700

Stock Details

Ticker Symbol HQH
Exchange NYSE
Reporting Currency USD
CIK Code 0000805267
CUSIP Number 87911J103
ISIN Number US87911J1034
Employer ID 04-6564285

Key Executives

Name Position
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager
Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager

Latest SEC Filings

Date Type Title
Sep 3, 2024 N-PX Annual Report of proxy voting record of management investment companies
Aug 28, 2024 NPORT-P Monthly Portfolio Investments Report on Form N-PORT (Public)
Aug 15, 2024 40-17G Filing
Jun 10, 2024 N-CSRS Filing
May 29, 2024 NPORT-P Monthly Portfolio Investments Report on Form N-PORT (Public)
May 3, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Apr 22, 2024 DEF 14A Other definitive proxy statements
Mar 15, 2024 SC 13D General statement of acquisition of beneficial ownership
Feb 29, 2024 NPORT-P Monthly Portfolio Investments Report on Form N-PORT (Public)
Feb 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals